T. Tsuruo, H. Iida; S. Tsukagoshi; Y. Sakurai, 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent., in Cancer Res, vol. 42, n. 4, Apr 1982, pp. 1462-7, PMID 7060020.
H. Umezawa, Y. Takahashi; T. Takeuchi; H. Nakamura; Y. Iitaka; K. Tatsuta, The absolute structures of THP-adriamycins., in J Antibiot (Tokyo), vol. 37, n. 9, Sep 1984, pp. 1094-7, PMID 6501106.
T. Hisamatsu, K. Suzuki; S. Sakakibara; K. Komuro; M. Nagasawa; T. Takeuchi; H. Umezawa, Antitumor spectrum of a new anthracycline, (2R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice., in Jpn J Cancer Res, vol. 76, n. 10, Oct 1985, pp. 1008-20, PMID 3935619.
S. Kunimoto, K. Miura; Y. Takahashi; T. Takeuchi; H. Umezawa, Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyladriamycin., in J Antibiot (Tokyo), vol. 36, n. 3, Mar 1983, pp. 312-7, PMID 6833151.
S. Kunimoto, K. Miura; K. Umezawa; CZ. Xu; T. Masuda; T. Takeuchi; H. Umezawa, Cellular uptake and efflux and cytostatic activity of 4'-O-tetrahydropyranyladriamycin in adriamycin-sensitive and resistant tumor cell lines., in J Antibiot (Tokyo), vol. 37, n. 12, Dec 1984, pp. 1697-702, PMID 6526737.
AA. Miller, CG. Schmidt, Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycin., in Cancer Res, vol. 47, n. 5, Mar 1987, pp. 1461-5, PMID 3815348.
Y. Matsushita, H. Iguchi; T. Kiyosaki; H. Tone; T. Ishikura; T. Takeuchi; H. Umezawa, A high performance liquid chromatographic method of analysis of 4'-O-tetrahydropyranyladriamycin and their metabolites in biological samples., in J Antibiot (Tokyo), vol. 36, n. 7, Jul 1983, pp. 880-6, PMID 6885639.
H. Iguchi, H. Tone; T. Ishikura; T. Takeuchi; H. Umezawa, Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis., in Cancer Chemother Pharmacol, vol. 15, n. 2, 1985, pp. 132-40, PMID 4017162.
H. Iguchi, H. Tone; T. Kiyosaki; T. Ishikura; T. Takeuchi; H. Umezawa, Pharmacokinetics and disposition of (2"R)-4'-O-tetrahydropyranyladriamycin in dogs., in Jpn J Antibiot, vol. 39, n. 2, Feb 1986, pp. 638-52, PMID 3712763.
H. Tone, H. Iguchi; M. Fujigaki; M. Nishio; Y. Esumi; M. Takaichi; S. Tsutsumi; T. Yokoshima, [Pharmacokinetics and disposition of a new anticancer antibiotic (2"R)-4'-O-tetrahydropyranyladriamycin in rats. Distribution and excretion after a single administration]., in Jpn J Antibiot, vol. 39, n. 2, Feb 1986, pp. 612-28, PMID 3712761.
G. Mathé, H. Umezawa; S. Oka; JL. Misset; S. Brienza; F. de Vassal; M. Musset; P. Ribaud; H. Tapiero, An oriented phase II trial of THP-adriamycin in breast carcinoma., in Biomed Pharmacother, vol. 40, n. 10, 1986, pp. 376-9, PMID 3580506.
H. Lenk, S. Tanneberger; N. Wiener; H. Giesske; S. Gärtner; J. Geyer; KH. Rotte, Phase II study of pirarubicin (THP-adriamycin) in metastatic breast cancer patients., in Oncology, vol. 47, n. 2, 1990, pp. 97-100, PMID 2314831.
R. Ohno, K. Kimura; I. Amaki; M. Hirano; A. Hoshino; Y. Ikeda; I. Kimura; M. Kobayashi; K. Konno; H. Majima, Treatment of acute leukemia and malignant lymphoma with (2R)-4'-O-tetrahydropyranyladriamycin., in Cancer Chemother Pharmacol, vol. 20, n. 3, 1987, pp. 230-4, PMID 3315282.
T. Takagi, M. Oguro; K. Iwabuchi, [Effects of single administration of tetrahydropyranyladriamycin (THP) in lymphoid malignancy]., in Gan To Kagaku Ryoho, vol. 11, n. 7, Jul 1984, pp. 1450-6, PMID 6588924.
T. Takagi, M. Oguro, (2-R)-4'-o-tetrahydropyranyladriamycin, a new anthracycline derivative; its effectiveness in lymphoid malignancies., in Cancer Chemother Pharmacol, vol. 20, n. 2, 1987, pp. 151-4, PMID 3478154.
H. Majima, K. Ohta, Clinical studies of (2"R)-4'-O-tetrahydropyranyl adriamycin (THP)., in Biomed Pharmacother, vol. 41, n. 5, 1987, pp. 237-43, PMID 3311190.
H. Stöger, T. Bauernhofer; M. Schmid; F. Ploner; R. Moser; E. Derstvenscheg; P. Steindorfer; M. Wilders-Truschnig; I. Kuss; H. Samonigg, A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients., in Cancer Chemother Pharmacol, vol. 35, n. 2, 1994, pp. 174-8, PMID 7987997.
K. Okuma, Y. Ariyoshi; K. Ota, [Clinical study of acute cardiotoxicity of anti-cancer agents-- analysis using Holter ECG monitoring]., in Gan To Kagaku Ryoho, vol. 15, n. 6, Jun 1988, pp. 1893-900, PMID 3164181.
K. Okuma, I. Furuta; K. Ota, [Acute cardiotoxicity of anthracyclines--analysis by using Holter ECG]., in Gan To Kagaku Ryoho, vol. 11, n. 4, Apr 1984, pp. 902-11, PMID 6202243.
S. Hirano, K. Wakazono; N. Agata; H. Iguchi; H. Tone, Comparison of cardiotoxicity of pirarubicin, epirubicin and doxorubicin in the rat., in Drugs Exp Clin Res, vol. 20, n. 4, 1994, pp. 153-60, PMID 7813387.
M. Suzuki, M. Hirono; H. Majima, [Cardiotoxicity due to prolonged administration of THP (2R-4'-O-tetrahydropyranyl-adriamycin)]., in Gan To Kagaku Ryoho, vol. 24, n. 13, Oct 1997, pp. 1993-9, PMID 9350248.
Y. Okada, K. Horikawa; M. Sano, [Echocardiographic evaluation of cardiotoxicity induced by anthracycline therapy]., in Gan To Kagaku Ryoho, vol. 24, n. 5, Mar 1997, pp. 585-9, PMID 9087292.
N. Niitsu, J. Yamazaki; M. Nakayama; M. Umeda, Pirarubicin-induced myocardial damage in elderly patients with non-Hodgkin's lymphoma., in Nihon Ronen Igakkai Zasshi, vol. 35, n. 5, maggio 1998, pp. 358-62, PMID 9735010.
